Biotechnology
The Biotechnology industry has a total of 588 stocks, with a combined market cap of $1.25 trillion and total revenue of $109.89 billion.
Market Cap
1.25T
Revenue
109.89B
Profits
-41.36B
PE Ratio
n/a
Profit Margin
-37.64%
Dividend Yield
0.04%
588 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 126.32B | 0.20% | 729,869 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 63.67B | 0.36% | 718,502 | 14.92B |
| 3 | ARGX | argenx SE | 57.65B | -1.64% | 309,806 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.79B | 1.49% | 623,775 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 39.73B | -0.22% | 1,383,303 | - |
| 6 | ONC | BeOne Medicines AG | 32.26B | 1.83% | 268,081 | 5.70B |
| 7 | RPRX | Royalty Pharma plc | 32.11B | -0.56% | 1,472,878 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 28.41B | 2.26% | 4,758,910 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.20B | -1.00% | 2,592,505 | 8.26M |
| 10 | BNTX | BioNTech SE | 23.61B | 0.34% | 364,356 | 3.23B |
| 11 | INSM | Insmed Incorporated | 23.17B | 0.25% | 1,427,361 | 819.56M |
| 12 | INCY | Incyte Corporation | 22.77B | 0.54% | 761,000 | 5.36B |
| 13 | GMAB | Genmab A/S | 16.84B | 0.29% | 1,196,961 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.54B | -0.14% | 341,631 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.92B | -1.29% | 449,933 | 4.44B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.69B | 0.67% | 1,734,932 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.58B | -0.68% | 1,016,863 | 2.38B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 13.08B | -0.18% | 880,554 | 1.06B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.29B | -2.40% | 515,243 | 708.24M |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.89B | -3.98% | 184,772 | 1.13B |
| 21 | CYTK | Cytokinetics, Incorporated | 11.56B | -0.04% | 1,288,963 | 105.82M |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.36B | -1.07% | 1,357,216 | 622.01M |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 11.17B | 0.96% | 911,971 | 3.24B |
| 24 | SMMT | Summit Therapeutics Inc. | 11.14B | -1.51% | 2,660,269 | - |
| 25 | TECH | Bio-Techne Corporation | 11.02B | 0.11% | 10,096,463 | 1.21B |
| 26 | KRYS | Krystal Biotech, Inc. | 10.95B | -0.07% | 210,707 | 417.30M |
| 27 | ABVX | ABIVAX Société Anonyme | 10.52B | 0.35% | 3,720,220 | 5.67M |
| 28 | APGE | Apogee Therapeutics, Inc. | 9.95B | -0.02% | 2,685,302 | - |
| 29 | NUVL | Nuvalent, Inc. | 9.76B | 0.07% | 561,535 | - |
| 30 | IBRX | ImmunityBio, Inc. | 9.64B | 5.14% | 13,001,910 | 140.98M |
| 31 | CORT | Corcept Therapeutics Incorporated | 9.61B | 2.94% | 658,824 | 769.10M |
| 32 | KYMR | Kymera Therapeutics, Inc. | 9.55B | 1.29% | 550,083 | 51.48M |
| 33 | HALO | Halozyme Therapeutics, Inc. | 9.13B | -1.60% | 998,806 | 1.51B |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 9.11B | -2.42% | 426,721 | 7.46M |
| 35 | PCVX | Vaxcyte, Inc. | 8.07B | -3.84% | 992,304 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 8.04B | 2.01% | 302,434 | 74.06M |
| 37 | IMVT | Immunovant, Inc. | 7.79B | -1.48% | 428,988 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 7.67B | -0.56% | 814,499 | - |
| 39 | TGTX | TG Therapeutics, Inc. | 7.62B | -2.15% | 1,080,820 | 700.35M |
| 40 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.59B | -0.25% | 757,480 | 217.17M |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 7.26B | 1.65% | 748,193 | 569.61M |
| 42 | PTCT | PTC Therapeutics, Inc. | 6.76B | -0.07% | 723,437 | 827.11M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.55B | -1.01% | 1,653,664 | - |
| 44 | SRRK | Scholar Rock Holding Corporation | 6.37B | -3.38% | 803,224 | - |
| 45 | CGON | CG Oncology, Inc. | 6.24B | -0.42% | 640,418 | 5.07M |
| 46 | LGND | Ligand Pharmaceuticals Incorporated | 6.17B | -1.40% | 339,102 | 274.48M |
| 47 | XENE | Xenon Pharmaceuticals Inc. | 5.83B | -0.04% | 877,399 | 7.50M |
| 48 | DFTX | Definium Therapeutics, Inc. | 5.82B | -6.78% | 1,994,164 | - |
| 49 | LEGN | Legend Biotech Corporation | 5.80B | 3.77% | 1,148,417 | 1.14B |
| 50 | BLTE | Belite Bio, Inc | 5.76B | -4.88% | 195,757 | - |
| 51 | ORKA | Oruka Therapeutics, Inc. | 5.67B | -1.16% | 898,145 | - |
| 52 | ERAS | Erasca, Inc. | 5.59B | -1.97% | 2,601,543 | - |
| 53 | MANE | Veradermics, Incorporated | 5.38B | 4.74% | 365,747 | - |
| 54 | CRSP | CRISPR Therapeutics AG | 5.34B | 1.54% | 676,758 | 4.10M |
| 55 | CAI | Caris Life Sciences, Inc. | 5.25B | 4.26% | 3,049,734 | 907.29M |
| 56 | TVTX | Travere Therapeutics, Inc. | 5.25B | -0.67% | 843,049 | 536.20M |
| 57 | CELC | Celcuity Inc. | 5.08B | -0.33% | 742,444 | - |
| 58 | DNTH | Dianthus Therapeutics, Inc. | 5.04B | -5.46% | 612,860 | 1.34M |
| 59 | ACAD | ACADIA Pharmaceuticals Inc. | 4.32B | -0.36% | 821,496 | 1.10B |
| 60 | VKTX | Viking Therapeutics, Inc. | 4.31B | -4.90% | 2,202,210 | - |
| 61 | TNGX | Tango Therapeutics, Inc. | 4.24B | -6.33% | 1,837,705 | 56.99M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 4.23B | -3.22% | 883,571 | - |
| 63 | DNLI | Denali Therapeutics Inc. | 4.11B | 0.60% | 797,109 | - |
| 64 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.06B | 2.85% | 749,768 | 18.07M |
| 65 | NAMS | NewAmsterdam Pharma Company N.V. | 4.05B | 2.24% | 459,392 | 22.57M |
| 66 | TLX | Telix Pharmaceuticals Limited | 4.00B | 3.04% | 133,541 | 803.79M |
| 67 | RLAY | Relay Therapeutics, Inc. | 3.90B | -4.33% | 1,901,953 | 10.68M |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 515,012 | 596.96M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.73B | -2.11% | 1,292,512 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.63B | -6.36% | 943,416 | 236.00M |
| 71 | DYN | Dyne Therapeutics, Inc. | 3.63B | -1.22% | 953,157 | - |
| 72 | PBLS | Parabilis Medicines, Inc. | 3.54B | 1.68% | 415,391 | - |
| 73 | IDYA | IDEAYA Biosciences, Inc. | 3.41B | -3.73% | 705,901 | 225.27M |
| 74 | ELVN | Enliven Therapeutics, Inc. | 3.39B | -4.39% | 618,974 | - |
| 75 | ALMS | Alumis Inc. | 3.37B | -6.11% | 686,575 | 8.40M |
| 76 | BEAM | Beam Therapeutics Inc. | 3.30B | -3.41% | 1,440,700 | 164.01M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 3.26B | -0.50% | 443,050 | 415.62M |
| 78 | RARE | Ultragenyx Pharmaceutical Inc. | 3.21B | -1.96% | 1,437,649 | 670.00M |
| 79 | QURE | uniQure N.V. | 3.13B | -1.22% | 792,842 | 18.09M |
| 80 | VERA | Vera Therapeutics, Inc. | 3.06B | -0.72% | 816,816 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.88B | -1.29% | 318,806 | 865.00K |
| 82 | IRON | Disc Medicine, Inc. | 2.85B | 2.01% | 591,573 | - |
| 83 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -6.04% | 632,230 | - |
| 84 | MBX | MBX Biosciences, Inc. | 2.67B | 1.81% | 736,711 | - |
| 85 | TARS | Tarsus Pharmaceuticals, Inc. | 2.60B | -3.86% | 1,786,853 | 535.08M |
| 86 | SLS | SELLAS Life Sciences Group, Inc. | 2.54B | -7.59% | 9,979,052 | - |
| 87 | TRVI | Trevi Therapeutics, Inc. | 2.51B | -5.15% | 2,062,205 | - |
| 88 | NRIX | Nurix Therapeutics, Inc. | 2.47B | -1.38% | 767,111 | 71.78M |
| 89 | IMNM | Immunome, Inc. | 2.43B | 1.37% | 1,389,302 | 4.02M |
| 90 | NTLA | Intellia Therapeutics, Inc. | 2.42B | 2.42% | 2,573,982 | 66.09M |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.63% | 846,825 | - |
| 92 | PHVS | Pharvaris N.V. | 2.36B | -2.14% | 148,592 | - |
| 93 | BHVN | Biohaven Ltd. | 2.34B | 4.64% | 3,720,314 | - |
| 94 | ABCL | AbCellera Biologics Inc. | 2.33B | -2.80% | 7,011,186 | 79.21M |
| 95 | VCEL | Vericel Corporation | 2.32B | 2.07% | 386,838 | 292.09M |
| 96 | KOD | Kodiak Sciences Inc. | 2.29B | -5.78% | 365,397 | - |
| 97 | NKTR | Nektar Therapeutics | 2.21B | -6.42% | 862,481 | 55.63M |
| 98 | AGIO | Agios Pharmaceuticals, Inc. | 2.20B | -0.15% | 795,771 | 66.05M |
| 99 | ZLAB | Zai Lab Limited | 2.16B | 1.16% | 443,612 | 453.28M |
| 100 | TSHA | Taysha Gene Therapies, Inc. | 2.14B | -1.84% | 2,069,546 | 7.47M |
| 101 | KARD | Kardigan, Inc. | 2.13B | 0.13% | 606,385 | - |
| 102 | GENB | Generate Biomedicines, Inc. | 2.12B | -2.05% | 701,167 | 30.30M |
| 103 | HRMY | Harmony Biosciences Holdings, Inc. | 2.09B | -0.71% | 306,491 | 899.11M |
| 104 | VRDN | Viridian Therapeutics, Inc. | 2.09B | 3.10% | 2,169,853 | 70.92M |
| 105 | OCUL | Ocular Therapeutix, Inc. | 2.07B | -3.56% | 1,350,964 | 52.04M |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 2.05B | -6.13% | 1,481,760 | 298.30M |
| 107 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.76% | 720,922 | 32.08M |
| 108 | GLUE | Monte Rosa Therapeutics, Inc. | 2.02B | -1.32% | 809,350 | 42.95M |
| 109 | ADMA | ADMA Biologics, Inc. | 1.99B | 2.75% | 2,002,746 | 509.86M |
| 110 | LKFT | Lakefront Biotherapeutics NV | 1.97B | -1.03% | 223,884 | 1.20B |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.97B | -10.18% | 290,086 | - |
| 112 | RXRX | Recursion Pharmaceuticals, Inc. | 1.96B | 0.41% | 30,473,112 | 66.41M |
| 113 | ANAB | AnaptysBio, Inc. | 1.94B | -1.44% | 251,732 | 232.39M |
| 114 | SRPT | Sarepta Therapeutics, Inc. | 1.92B | 1.34% | 2,266,106 | 2.18B |
| 115 | NBTX | Nanobiotix S.A. | 1.92B | 5.12% | 68,407 | 38.27M |
| 116 | PGEN | Precigen, Inc. | 1.91B | -5.79% | 5,112,615 | 31.60M |
| 117 | BCAX | Bicara Therapeutics Inc. | 1.91B | -1.99% | 542,485 | - |
| 118 | URGN | UroGen Pharma Ltd. | 1.91B | 6.30% | 761,734 | 140.49M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.90B | -4.84% | 206,929 | 20.00M |
| 120 | SION | Sionna Therapeutics, Inc. | 1.89B | -4.68% | 266,469 | - |
| 121 | NUVB | Nuvation Bio Inc. | 1.88B | -5.19% | 5,769,939 | 143.05M |
| 122 | ZYME | Zymeworks Inc. | 1.87B | -2.14% | 380,266 | 81.26M |
| 123 | ABSI | Absci Corporation | 1.87B | -5.00% | 4,011,853 | 1.84M |
| 124 | SNDX | Syndax Pharmaceuticals, Inc. | 1.84B | -5.03% | 1,379,006 | 217.17M |
| 125 | MESO | Mesoblast Limited | 1.83B | 3.70% | 202,201 | 65.38M |
| 126 | GHRS | GH Research PLC | 1.81B | -1.71% | 129,431 | - |
| 127 | ATAI | AtaiBeckley Inc. | 1.81B | -6.64% | 6,829,765 | 3.49M |
| 128 | ZBIO | Zenas BioPharma, Inc. | 1.78B | 11.07% | 1,963,591 | 10.00M |
| 129 | TYRA | Tyra Biosciences, Inc. | 1.76B | -7.51% | 427,953 | - |
| 130 | AKTS | Aktis Oncology, Inc. | 1.75B | -1.89% | 254,131 | 8.28M |
| 131 | IOVA | Iovance Biotherapeutics, Inc. | 1.74B | -6.37% | 16,241,164 | 285.61M |
| 132 | FTRE | Fortrea Holdings Inc. | 1.65B | 0.23% | 983,296 | 2.71B |
| 133 | MAZE | Maze Therapeutics, Inc. | 1.64B | -0.57% | 637,032 | 20.00M |
| 134 | DMRA | Damora Therapeutics, Inc. | 1.64B | 2.54% | 423,105 | - |
| 135 | MPLT | MapLight Therapeutics, Inc. | 1.64B | 0.95% | 291,732 | - |
| 136 | INVA | Innoviva, Inc. | 1.62B | -3.08% | 423,416 | 420.69M |
| 137 | VIR | Vir Biotechnology, Inc. | 1.61B | -6.08% | 1,372,072 | 65.50M |
| 138 | AVBP | ArriVent BioPharma, Inc. | 1.61B | -0.32% | 209,735 | - |
| 139 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.60B | -0.48% | 1,584,034 | 204.73M |
| 140 | IMCR | Immunocore Holdings plc | 1.60B | -0.98% | 557,595 | 412.81M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.58B | -1.69% | 721,943 | - |
| 142 | SEPN | Septerna, Inc. | 1.57B | 3.79% | 280,997 | 72.26M |
| 143 | AAPG | Ascentage Pharma Group International | 1.56B | 0.43% | 13,145 | 82.08M |
| 144 | NVAX | Novavax, Inc. | 1.54B | -0.32% | 3,625,677 | 596.34M |
| 145 | COAG | Hemab Therapeutics Holdings, Inc. | 1.54B | -10.13% | 120,899 | - |
| 146 | SVRA | Savara Inc. | 1.54B | -1.62% | 986,521 | - |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.38B | -1.02% | 240,121 | 1.30M |
| 148 | CAPR | Capricor Therapeutics, Inc. | 1.35B | -3.24% | 1,280,029 | 11.13M |
| 149 | IMTX | Immatics N.V. | 1.34B | -2.86% | 186,379 | 43.00M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.33B | -8.63% | 425,911 | - |
| 151 | JBIO | Jade Biosciences, Inc. | 1.29B | -1.94% | 370,887 | - |
| 152 | MNKD | MannKind Corporation | 1.28B | -3.05% | 1,623,138 | 360.78M |
| 153 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | 1.27% | 1,474,525 | - |
| 154 | ARDX | Ardelyx, Inc. | 1.27B | 0.59% | 3,996,712 | 427.68M |
| 155 | MGTX | MeiraGTx Holdings plc | 1.18B | -5.77% | 1,096,695 | 79.76M |
| 156 | DRTS | Alpha Tau Medical Ltd. | 1.16B | 2.46% | 917,914 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.16B | -0.46% | 66,064 | - |
| 158 | XNCR | Xencor, Inc. | 1.15B | -3.39% | 668,170 | 97.36M |
| 159 | WVE | Wave Life Sciences Ltd. | 1.15B | 2.58% | 1,831,577 | 71.80M |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.14B | 1.29% | 1,052,141 | - |
| 161 | EYPT | EyePoint, Inc. | 1.13B | -5.45% | 1,629,686 | 7.61M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.07B | -4.56% | 457,394 | - |
| 163 | SANA | Sana Biotechnology, Inc. | 1.06B | 0.86% | 2,292,221 | - |
| 164 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.05B | -1.04% | 1,707,332 | 69.64M |
| 165 | OLMA | Olema Pharmaceuticals, Inc. | 1.04B | -5.04% | 1,661,654 | - |
| 166 | VOR | Vor Biopharma Inc. | 998.10M | 0.05% | 1,070,336 | - |
| 167 | SLDB | Solid Biosciences Inc. | 969.24M | -1.45% | 771,029 | - |
| 168 | PHAR | Pharming Group N.V. | 964.46M | -1.69% | 4,396 | 369.49M |
| 169 | KURA | Kura Oncology, Inc. | 956.99M | -1.73% | 1,287,360 | 71.64M |
| 170 | DBVT | DBV Technologies S.A. | 953.36M | -4.15% | 218,423 | 5.74M |
| 171 | REPL | Replimune Group, Inc. | 946.90M | 1.90% | 1,925,690 | - |
| 172 | ABUS | Arbutus Biopharma Corporation | 938.30M | -1.04% | 2,161,579 | 191.45M |
| 173 | AVTX | Avalo Therapeutics, Inc. | 921.47M | -5.14% | 1,161,673 | 59.00K |
| 174 | LBRX | LB Pharmaceuticals Inc | 909.34M | -2.30% | 140,511 | - |
| 175 | ANNX | Annexon, Inc. | 907.69M | -2.98% | 4,098,563 | - |
| 176 | JANX | Janux Therapeutics, Inc. | 898.30M | -4.10% | 1,075,761 | 13.73M |
| 177 | ANRO | Alto Neuroscience, Inc. | 895.60M | -3.30% | 242,957 | - |
| 178 | DSGN | Design Therapeutics, Inc. | 888.14M | -1.73% | 860,957 | - |
| 179 | TBPH | Theravance Biopharma, Inc. | 875.37M | -0.12% | 887,228 | 109.78M |
| 180 | IVA | Inventiva S.A. | 869.21M | -2.12% | 963,468 | 7.94M |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 837.99M | -2.76% | 519,820 | 204.89M |
| 182 | ZVRA | Zevra Therapeutics, Inc. | 825.25M | -2.65% | 719,635 | 122.29M |
| 183 | OCS | Oculis Holding AG | 824.30M | -1.59% | 307,319 | 1.40M |
| 184 | ODTX | Odyssey Therapeutics, Inc. | 813.45M | -9.19% | 197,300 | 1.06M |
| 185 | GERN | Geron Corporation | 811.52M | -1.17% | 8,333,884 | 196.12M |
| 186 | CTMX | CytomX Therapeutics, Inc. | 794.62M | -2.67% | 3,355,425 | 35.54M |
| 187 | SPRY | ARS Pharmaceuticals, Inc. | 785.49M | -1.25% | 741,401 | 98.99M |
| 188 | CLYM | Climb Bio, Inc. | 756.41M | 1.30% | 1,273,719 | - |
| 189 | ACRS | Aclaris Therapeutics, Inc. | 756.28M | 2.36% | 1,750,207 | 8.37M |
| 190 | ALLO | Allogene Therapeutics, Inc. | 740.36M | 3.12% | 10,626,569 | 22.00K |
| 191 | CADL | Candel Therapeutics, Inc. | 732.70M | -2.91% | 1,472,627 | - |
| 192 | AURA | Aura Biosciences, Inc. | 729.08M | -6.90% | 363,256 | - |
| 193 | SLBT | SL Science Holding Limited | 720.85M | -6.89% | 228,412 | - |
| 194 | RIGL | Rigel Pharmaceuticals, Inc. | 715.20M | -1.19% | 164,983 | 299.77M |
| 195 | DRUG | Bright Minds Biosciences Inc. | 704.76M | -4.34% | 274,220 | - |
| 196 | IMMX | Immix Biopharma, Inc. | 698.02M | -4.90% | 1,184,752 | - |
| 197 | OMER | Omeros Corporation | 696.25M | 1.16% | 759,371 | 9.89M |
| 198 | DNA | Ginkgo Bioworks Holdings, Inc. | 686.56M | 6.05% | 1,182,449 | 151.40M |
| 199 | PRME | Prime Medicine, Inc. | 685.44M | 2.85% | 2,867,399 | 4.03M |
| 200 | TENX | Tenax Therapeutics, Inc. | 682.59M | -8.18% | 646,681 | - |
| 201 | RGNX | REGENXBIO Inc. | 679.31M | 9.68% | 3,464,468 | 87.82M |
| 202 | EIKN | Eikon Therapeutics, Inc. | 674.30M | -4.56% | 548,520 | - |
| 203 | FDMT | 4D Molecular Therapeutics, Inc. | 670.70M | -3.53% | 778,012 | 88.24M |
| 204 | CRMD | CorMedix Inc. | 667.63M | 8.41% | 995,804 | 400.05M |
| 205 | RLMD | Relmada Therapeutics, Inc. | 663.96M | -8.53% | 973,710 | - |
| 206 | SGP | SpyGlass Pharma, Inc. | 661.40M | -11.13% | 66,637 | - |
| 207 | ACHV | Achieve Life Sciences, Inc. | 646.75M | -3.52% | 3,301,618 | - |
| 208 | MNPR | Monopar Therapeutics Inc. | 638.86M | 3.00% | 160,904 | - |
| 209 | ALT | Altimmune, Inc. | 624.26M | 5.59% | 6,619,363 | 36.00K |
| 210 | TRAX | First Tracks Biotherapeutics, Inc. | 623.18M | -11.23% | 277,225 | - |
| 211 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 620.83M | 1.71% | 322,886 | - |
| 212 | TECX | Tectonic Therapeutic, Inc. | 614.76M | -5.22% | 174,770 | - |
| 213 | GYRE | Gyre Therapeutics, Inc. | 600.31M | -0.30% | 61,544 | 117.05M |
| 214 | FTH | Faeth Therapeutics, Inc. | 596.65M | -7.42% | 92,804 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 585.56M | -8.40% | 87,112 | - |
| 216 | MDXG | MiMedx Group, Inc. | 579.40M | 1.04% | 395,649 | 389.42M |
| 217 | PROK | ProKidney Corp. | 578.44M | -6.13% | 1,029,784 | 889.00K |
| 218 | CBIO | Crescent Biopharma, Inc. | 576.03M | -3.69% | 120,115 | 11.88M |
| 219 | CTNM | Contineum Therapeutics, Inc. | 575.00M | -6.16% | 213,554 | - |
| 220 | XOMA | XOMA Royalty Corporation | 534.00M | 0.19% | 83,619 | 48.56M |
| 221 | NGNE | Neurogene Inc. | 530.79M | 6.80% | 463,065 | 925.00K |
| 222 | FBRX | Forte Biosciences, Inc. | 527.32M | 1.55% | 258,067 | - |
| 223 | ARVN | Arvinas, Inc. | 523.91M | -2.29% | 443,323 | 89.40M |
| 224 | ASMB | Assembly Biosciences, Inc. | 523.67M | -3.84% | 161,234 | 71.10M |
| 225 | KYTX | Kyverna Therapeutics, Inc. | 521.62M | -3.70% | 514,770 | - |
| 226 | RZLT | Rezolute, Inc. | 511.89M | -5.77% | 1,690,255 | - |
| 227 | NVCT | Nuvectis Pharma, Inc. | 511.68M | 4.89% | 806,217 | - |
| 228 | OCGN | Ocugen, Inc. | 502.70M | -2.94% | 4,659,248 | 4.47M |
| 229 | SLN | Silence Therapeutics plc | 501.15M | -3.37% | 474,712 | 839.00K |
| 230 | STRO | Sutro Biopharma, Inc. | 500.59M | -9.01% | 337,324 | 99.61M |
| 231 | PRTA | Prothena Corporation plc | 498.40M | -2.76% | 289,168 | 57.94M |
| 232 | OVID | Ovid Therapeutics Inc. | 498.33M | -0.74% | 1,044,759 | 7.12M |
| 233 | STTK | Shattuck Labs, Inc. | 498.04M | -6.41% | 1,408,216 | 1.00M |
| 234 | ZURA | Zura Bio Limited | 496.84M | -11.36% | 1,354,351 | - |
| 235 | PRLD | Prelude Therapeutics Incorporated | 489.94M | -7.32% | 466,879 | 16.72M |
| 236 | VALN | Valneva SE | 488.58M | -2.67% | 17,063 | 180.25M |
| 237 | EDIT | Editas Medicine, Inc. | 487.24M | -2.01% | 2,045,859 | 38.69M |
| 238 | CABA | Cabaletta Bio, Inc. | 484.27M | -4.50% | 4,571,397 | - |
| 239 | ARTV | Artiva Biotherapeutics, Inc. | 479.08M | 1.65% | 234,774 | 251.00K |
| 240 | CCCC | C4 Therapeutics, Inc. | 476.54M | -7.71% | 4,362,241 | 34.86M |
| 241 | EVMN | Evommune, Inc. | 469.32M | -1.96% | 1,217,124 | 10.00M |
| 242 | SGMT | Sagimet Biosciences Inc. | 458.20M | -4.01% | 714,698 | - |
| 243 | IPSC | Century Therapeutics, Inc. | 446.38M | 1.02% | 1,650,595 | 109.16M |
| 244 | BNTC | Benitec Biopharma Inc. | 437.50M | -4.82% | 65,608 | - |
| 245 | VTVT | vTv Therapeutics Inc. | 436.94M | -6.48% | 46,075 | 36.84M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 428.62M | 1.10% | 135,286 | 69.21M |
| 247 | EPRX | Eupraxia Pharmaceuticals Inc. | 428.28M | 1.44% | 171,338 | - |
| 248 | AUTL | Autolus Therapeutics plc | 419.18M | -1.56% | 538,508 | 92.62M |
| 249 | ANL | Adlai Nortye Ltd. | 412.00M | -10.43% | 125,344 | 5.00M |
| 250 | PBYI | Puma Biotechnology, Inc. | 402.61M | -2.47% | 145,064 | 227.18M |
| 251 | DMAC | DiaMedica Therapeutics Inc. | 398.20M | 4.97% | 210,744 | - |
| 252 | HELP | Cybin Inc. | 392.98M | -4.08% | 847,969 | - |
| 253 | UPB | Upstream Bio, Inc. | 392.37M | 4.19% | 401,019 | 3.32M |
| 254 | CMPX | Compass Therapeutics, Inc. | 391.69M | -0.68% | 1,765,611 | 850.00K |
| 255 | XFOR | X4 Pharmaceuticals, Inc. | 384.35M | -12.74% | 665,833 | 9.01M |
| 256 | RCKT | Rocket Pharmaceuticals, Inc. | 376.72M | 0.88% | 2,315,447 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 375.33M | 0.86% | 315,362 | - |
| 258 | FENC | Fennec Pharmaceuticals Inc. | 361.96M | -3.07% | 177,031 | 51.00M |
| 259 | VNDA | Vanda Pharmaceuticals Inc. | 360.81M | -1.96% | 499,915 | 217.78M |
| 260 | FATE | Fate Therapeutics, Inc. | 356.67M | 13.33% | 4,797,438 | 6.32M |
| 261 | GLSI | Greenwich LifeSciences, Inc. | 354.04M | 2.81% | 67,424 | - |
| 262 | ABEO | Abeona Therapeutics Inc. | 352.80M | 0.16% | 1,588,581 | 14.54M |
| 263 | OABI | OmniAb, Inc. | 350.11M | -1.83% | 253,458 | 28.94M |
| 264 | IFRX | InflaRx N.V. | 349.82M | 6.03% | 1,439,414 | 33.82K |
| 265 | PALI | Palisade Bio, Inc. | 344.56M | -5.02% | 3,343,856 | - |
| 266 | VSTM | Verastem, Inc. | 344.46M | 2.62% | 1,320,888 | 49.59M |
| 267 | IRD | Opus Genetics, Inc. | 343.49M | 2.68% | 601,002 | 11.98M |
| 268 | LXEO | Lexeo Therapeutics, Inc. | 343.14M | -6.12% | 636,808 | - |
| 269 | INDP | Indaptus Therapeutics, Inc. | 331.80M | -2.33% | 41,808 | - |
| 270 | IKT | Inhibikase Therapeutics, Inc. | 328.92M | -4.93% | 531,915 | 1.00 |
| 271 | LRMR | Larimar Therapeutics, Inc. | 326.20M | 2.46% | 2,051,758 | - |
| 272 | LCTX | Lineage Cell Therapeutics, Inc. | 322.84M | -1.15% | 539,001 | 14.78M |
| 273 | IMRX | Immuneering Corporation | 322.84M | - | 816,379 | - |
| 274 | ZNTL | Zentalis Pharmaceuticals, Inc. | 306.81M | -11.13% | 888,680 | 26.87M |
| 275 | ADAG | Adagene Inc. | 304.93M | 9.88% | 1,197,343 | 7.67M |
| 276 | ELDN | Eledon Pharmaceuticals, Inc. | 304.18M | -0.13% | 1,353,677 | - |
| 277 | RNAC | Cartesian Therapeutics, Inc. | 300.87M | -1.73% | 102,413 | 1.78M |
| 278 | NMRA | Neumora Therapeutics, Inc. | 297.38M | -5.59% | 683,710 | - |
| 279 | FHTX | Foghorn Therapeutics Inc. | 295.33M | 3.07% | 209,418 | 28.22M |
| 280 | SRZN | Surrozen, Inc. | 294.79M | -2.16% | 67,303 | 7.49M |
| 281 | SABS | SAB Biotherapeutics, Inc. | 294.39M | -1.28% | 228,565 | 114.70K |
| 282 | LYEL | Lyell Immunopharma, Inc. | 293.31M | -10.53% | 114,081 | 31.00K |
| 283 | BCYC | Bicycle Therapeutics plc | 292.51M | -1.18% | 165,952 | 63.50M |
| 284 | MGNX | MacroGenics, Inc. | 291.75M | -0.65% | 519,919 | 157.08M |
| 285 | GALT | Galectin Therapeutics Inc. | 287.79M | -5.82% | 524,818 | - |
| 286 | ALXO | ALX Oncology Holdings Inc. | 280.56M | 0.72% | 890,780 | - |
| 287 | CNXU | Conexeu Sciences Inc. | 277.22M | -5.13% | 48,930 | - |
| 288 | TRDA | Entrada Therapeutics, Inc. | 267.73M | 0.95% | 182,839 | 5.74M |
| 289 | NAGE | Niagen Bioscience, Inc. | 265.77M | 4.39% | 397,893 | 130.42M |
| 290 | OBIO | Orchestra BioMed Holdings, Inc. | 260.48M | 0.81% | 211,765 | 32.72M |
| 291 | NERV | Minerva Neurosciences, Inc. | 252.51M | -2.34% | 73,286 | - |
| 292 | PRQR | ProQR Therapeutics N.V. | 249.08M | -5.11% | 1,226,490 | 15.73M |
| 293 | IVVD | Invivyd, Inc. | 248.41M | -3.35% | 2,355,738 | 55.87M |
| 294 | FULC | Fulcrum Therapeutics, Inc. | 247.88M | 1.64% | 1,007,861 | 80.00M |
| 295 | NAUT | Nautilus Biotechnology, Inc. | 238.91M | 0.53% | 2,175,785 | - |
| 296 | AVXL | Anavex Life Sciences Corp. | 238.17M | -0.77% | 872,175 | - |
| 297 | SLGL | Sol-Gel Technologies Ltd. | 237.26M | -2.10% | 17,564 | 18.47M |
| 298 | WHWK | Whitehawk Therapeutics, Inc. | 237.18M | -3.71% | 241,029 | 7.15M |
| 299 | ACIU | AC Immune SA | 232.63M | -1.47% | 572,259 | 4.62M |
| 300 | RNA | Atrium Therapeutics, Inc. | 230.07M | - | 94,687 | 36.68M |
| 301 | NBP | NovaBridge Biosciences | 229.56M | 1.79% | 736,604 | - |
| 302 | CAMP | Camp4 Therapeutics Corporation | 225.10M | -0.80% | 127,678 | 3.93M |
| 303 | TARA | Protara Therapeutics, Inc. | 224.25M | 4.45% | 1,222,816 | - |
| 304 | CHRS | Coherus Oncology, Inc. | 223.66M | 3.57% | 422,901 | 46.88M |
| 305 | ALEC | Alector, Inc. | 222.05M | -0.50% | 228,354 | 18.42M |
| 306 | NGEN | NervGen Pharma Corp. | 221.96M | 1.46% | 467,564 | - |
| 307 | ARMP | Armata Pharmaceuticals, Inc. | 220.63M | -7.25% | 41,814 | 5.20M |
| 308 | KPTI | Karyopharm Therapeutics Inc. | 217.56M | -1.74% | 240,000 | 151.12M |
| 309 | CLLS | Cellectis S.A. | 214.33M | -1.67% | 22,539 | 75.11M |
| 310 | QTTB | Q32 Bio Inc. | 214.33M | -0.78% | 161,160 | 53.74M |
| 311 | VYGR | Voyager Therapeutics, Inc. | 212.68M | 0.57% | 411,103 | 36.49M |
| 312 | CDXS | Codexis, Inc. | 212.24M | 3.32% | 841,519 | 78.09M |
| 313 | KROS | Keros Therapeutics, Inc. | 212.17M | 0.19% | 139,231 | 33.18M |
| 314 | NKTX | Nkarta, Inc. | 208.91M | 3.18% | 474,117 | - |
| 315 | TTRX | Turn Therapeutics Inc. | 206.73M | -4.93% | 44,313 | - |
| 316 | CNTN | Canton Strategic Holdings, Inc. | 205.92M | 4.61% | 212,136 | - |
| 317 | DTIL | Precision BioSciences, Inc. | 204.35M | 0.76% | 287,125 | 45.07M |
| 318 | IMUX | Immunic, Inc. | 203.51M | -2.80% | 64,945 | - |
| 319 | CGEN | Compugen Ltd. | 201.94M | -0.23% | 130,636 | 72.66M |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.03M | -3.13% | 229,152 | 17.56M |
| 321 | KRRO | Korro Bio, Inc. | 195.57M | 2.88% | 118,370 | 3.84M |
| 322 | ARCT | Arcturus Therapeutics Holdings Inc. | 194.98M | 2.08% | 330,701 | 54.71M |
| 323 | HUMA | Humacyte, Inc. | 191.87M | -8.82% | 15,090,194 | 2.02M |
| 324 | MDWD | MediWound Ltd. | 190.28M | 0.71% | 41,903 | 14.48M |
| 325 | EQ | Equillium, Inc. | 189.68M | -6.25% | 516,637 | 4.39M |
| 326 | ORMP | Oramed Pharmaceuticals Inc. | 188.67M | -4.16% | 904,326 | 2.00M |
| 327 | ABOS | Acumen Pharmaceuticals, Inc. | 187.07M | -3.00% | 217,480 | - |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 186.52M | -0.64% | 311,677 | 76.38M |
| 329 | PYXS | Pyxis Oncology, Inc. | 183.73M | -3.65% | 602,981 | 13.86M |
| 330 | OTLK | Outlook Therapeutics, Inc. | 180.69M | -5.97% | 8,106,496 | 333.14K |
| 331 | MIST | Milestone Pharmaceuticals Inc. | 180.27M | -1.12% | 899,892 | 1.78M |
| 332 | OKUR | OnKure Therapeutics, Inc. | 179.56M | -2.52% | 239,905 | - |
| 333 | LENZ | LENZ Therapeutics, Inc. | 177.94M | -0.09% | 384,718 | 20.99M |
| 334 | CRBU | Caribou Biosciences, Inc. | 175.05M | 0.28% | 1,497,360 | 11.20M |
| 335 | IPHA | Innate Pharma S.A. | 170.35M | 0.27% | 7,909 | 10.57M |
| 336 | ACOG | Alpha Cognition Inc. | 169.79M | 8.00% | 32,308 | 10.83M |
| 337 | ANTX | AN2 Therapeutics, Inc. | 169.46M | -2.79% | 75,263 | - |
| 338 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 168.23M | -3.20% | 253,852 | - |
| 339 | NRXP | NRx Pharmaceuticals, Inc. | 162.40M | -5.26% | 554,693 | 2.29M |
| 340 | TLSA | Tiziana Life Sciences Ltd | 162.28M | -1.95% | 121,787 | - |
| 341 | TNYA | Tenaya Therapeutics, Inc. | 161.06M | 0.42% | 1,060,775 | 225.00K |
| 342 | YDES | YD Bio Limited | 161.03M | 1.78% | 123,496 | 510.36K |
| 343 | KZIA | Kazia Therapeutics Limited | 156.89M | -2.49% | 114,069 | 1.27M |
| 344 | HURA | TuHURA Biosciences, Inc. | 155.39M | 4.27% | 497,429 | - |
| 345 | MENS | Jyong Biotech Ltd. | 154.41M | 0.48% | 46,770 | - |
| 346 | CNTB | Connect Biopharma Holdings Limited | 149.85M | - | 307,557 | 233.00K |
| 347 | ALDX | Aldeyra Therapeutics, Inc. | 146.28M | 13.85% | 2,700,444 | - |
| 348 | MOLN | Molecular Partners AG | 145.31M | 5.68% | 2,607 | 856.30K |
| 349 | ADCT | ADC Therapeutics SA | 145.00M | 6.54% | 1,294,131 | 79.18M |
| 350 | SPRB | Spruce Biosciences, Inc. | 143.93M | -3.16% | 42,242 | 697.00K |
| 351 | AGEN | Agenus Inc. | 139.92M | 9.80% | 491,823 | 123.87M |
| 352 | UNCY | Unicycive Therapeutics, Inc. | 138.84M | 10.87% | 5,070,234 | - |
| 353 | COYA | Coya Therapeutics, Inc. | 133.00M | -3.08% | 71,929 | 7.94M |
| 354 | ENLV | Enlivex Ltd. | 130.70M | -1.40% | 614,046 | - |
| 355 | SPRO | Spero Therapeutics, Inc. | 128.83M | 0.68% | 317,821 | 61.19M |
| 356 | GNLX | Genelux Corporation | 128.79M | -3.65% | 143,717 | 8.00K |
| 357 | PLYX | Polaryx Therapeutics, Inc. | 127.35M | 1.13% | 44,795 | - |
| 358 | PEPG | PepGen Inc. | 126.23M | 1.39% | 281,671 | - |
| 359 | GUTS | Fractyl Health, Inc. | 126.09M | 0.05% | 901,014 | 3.00K |
| 360 | AARD | Aardvark Therapeutics, Inc. | 121.30M | -3.47% | 198,662 | - |
| 361 | PMN | ProMIS Neurosciences, Inc. | 120.62M | 2.20% | 60,754 | - |
| 362 | ENGN | enGene Therapeutics Inc. | 118.24M | 2.02% | 513,325 | - |
| 363 | CUE | Cue Biopharma, Inc. | 115.98M | -9.17% | 30,020 | 32.73M |
| 364 | BDTX | Black Diamond Therapeutics, Inc. | 109.73M | 3.51% | 3,938,359 | 70.00M |
| 365 | ANIX | Anixa Biosciences, Inc. | 108.53M | 13.93% | 365,251 | - |
| 366 | NTHI | NeOnc Technologies Holdings, Inc. | 108.35M | -5.52% | 66,506 | 39.99K |
| 367 | ONCY | Oncolytics Biotech Inc. | 107.93M | -4.80% | 514,896 | - |
| 368 | CBUS | Cibus, Inc. | 107.25M | 2.55% | 92,951 | 4.29M |
| 369 | KLRS | Kalaris Therapeutics, Inc. | 106.83M | 10.32% | 45,965 | - |
| 370 | VANI | Vivani Medical, Inc. | 104.78M | -2.02% | 42,572 | - |
| 371 | CGTX | Cognition Therapeutics, Inc. | 102.03M | -0.87% | 2,062,353 | - |
| 372 | VRCA | Verrica Pharmaceuticals Inc. | 101.53M | -3.43% | 31,661 | 37.16M |
| 373 | FBIO | Fortress Biotech, Inc. | 101.32M | -0.33% | 201,884 | 66.16M |
| 374 | ATRA | Atara Biotherapeutics, Inc. | 100.55M | -2.79% | 29,622 | 23.14M |
| 375 | ICCC | ImmuCell Corporation | 100.24M | 10.25% | 48,518 | 29.93M |
| 376 | ATHE | Alterity Therapeutics Limited | 99.07M | 3.54% | 29,586 | 4.43M |
| 377 | BMEA | Biomea Fusion, Inc. | 97.60M | -8.16% | 1,290,648 | - |
| 378 | LIXT | Lixte Biotechnology Holdings, Inc. | 97.45M | 6.06% | 1,646,067 | - |
| 379 | ALPS | Alps Group Inc | 96.68M | 0.17% | 6,210 | 3.74M |
| 380 | PYPD | PolyPid Ltd. | 96.45M | -0.98% | 168,149 | - |
| 381 | PTHS | Pelthos Therapeutics Inc. | 95.81M | -2.46% | 29,426 | 27.70M |
| 382 | RANI | Rani Therapeutics Holdings, Inc. | 94.46M | 0.28% | 436,062 | 3.17M |
| 383 | INO | Inovio Pharmaceuticals, Inc. | 94.20M | 4.09% | 2,622,381 | 65.34K |
| 384 | RNTX | Rein Therapeutics Inc. | 90.24M | -6.74% | 761,276 | - |
| 385 | SEER | Seer, Inc. | 90.17M | -1.20% | 453,944 | 15.17M |
| 386 | ELTX | Elicio Therapeutics, Inc. | 89.06M | 19.44% | 1,727,248 | - |
| 387 | TELO | Telomir Pharmaceuticals, Inc. | 89.06M | 1.17% | 59,361 | - |
| 388 | ACET | Adicet Bio, Inc. | 88.94M | -1.97% | 78,603 | - |
| 389 | CRDF | Cardiff Oncology, Inc. | 88.54M | -0.38% | 446,144 | 525.00K |
| 390 | NRXS | NeurAxis, Inc. | 87.68M | -3.15% | 76,251 | 4.28M |
| 391 | ENTX | Entera Bio Ltd. | 87.13M | - | 382,371 | 42.00K |
| 392 | MAIA | MAIA Biotechnology, Inc. | 86.34M | -1.39% | 182,862 | - |
| 393 | IBIO | iBio, Inc. | 85.94M | -1.14% | 4,841,875 | 300.00K |
| 394 | CSBR | Champions Oncology, Inc. | 84.99M | -0.65% | 1,861 | 57.95M |
| 395 | RLYB | Rallybio Corporation | 84.88M | 0.12% | 15,022 | 858.00K |
| 396 | GANX | Gain Therapeutics, Inc. | 84.45M | -2.46% | 1,407,155 | - |
| 397 | OSTX | OS Therapies Incorporated | 81.28M | -3.95% | 522,869 | - |
| 398 | LONA | LeonaBio, Inc. | 80.97M | -6.20% | 24,849 | - |
| 399 | HRTX | Heron Therapeutics, Inc. | 80.88M | 0.12% | 3,299,063 | 150.71M |
| 400 | ANVS | Annovis Bio, Inc. | 80.83M | 2.15% | 627,773 | - |
| 401 | CING | Cingulate Inc. | 80.28M | 8.96% | 318,132 | - |
| 402 | GOSS | Gossamer Bio, Inc. | 80.02M | -0.55% | 9,422,304 | 55.54M |
| 403 | HYFT | MindWalk Holdings Corp. | 79.96M | 1.90% | 127,705 | 20.70M |
| 404 | OKYO | OKYO Pharma Limited | 77.23M | -1.89% | 22,994 | - |
| 405 | MCRB | Seres Therapeutics, Inc. | 76.26M | -0.19% | 137,390 | 1.15M |
| 406 | BYSI | BeyondSpring Inc. | 75.25M | 4.57% | 75,309 | 1.88M |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 73.62M | -3.37% | 254,622 | - |
| 408 | EXOZ | eXoZymes, Inc. | 71.65M | 0.24% | 49,437 | -700.00 |
| 409 | XBIT | XBiotech Inc. | 70.27M | 0.22% | 18,147 | - |
| 410 | EDSA | Edesa Biotech, Inc. | 69.78M | -3.48% | 40,216 | - |
| 411 | MNOV | MediciNova, Inc. | 69.65M | 7.20% | 407,114 | 596.64K |
| 412 | PLRX | Pliant Therapeutics, Inc. | 68.82M | -1.75% | 253,198 | - |
| 413 | TCRX | TScan Therapeutics, Inc. | 68.29M | 6.62% | 1,584,548 | 9.14M |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 66.40M | -7.09% | 231,301 | - |
| 415 | IMA | ImageneBio, Inc. | 65.42M | -1.69% | 6,544 | 800.00K |
| 416 | FLNA | Filana Therapeutics, Inc. | 60.38M | 5.04% | 296,297 | - |
| 417 | ATYR | aTyr Pharma, Inc. | 59.02M | 0.85% | 1,199,128 | 190.00K |
| 418 | IMMP | Immutep Limited | 58.11M | 5.04% | 738,528 | 5.28M |
| 419 | INKT | MiNK Therapeutics, Inc. | 57.29M | -1.63% | 10,565 | - |
| 420 | BOLD | Boundless Bio, Inc. | 55.93M | -0.40% | 278,608 | - |
| 421 | CNTX | Context Therapeutics Inc. | 55.21M | 8.49% | 4,128,035 | - |
| 422 | XLO | Xilio Therapeutics, Inc. | 54.38M | -5.11% | 19,545 | 53.48M |
| 423 | DWTX | Dogwood Therapeutics, Inc. | 53.47M | -1.24% | 66,757 | - |
| 424 | TIL | Instil Bio, Inc. | 52.56M | 0.78% | 12,385 | - |
| 425 | IBO | Impact BioMedical Inc. | 52.48M | 5.80% | 168,937 | 39.00K |
| 426 | MREO | Mereo BioPharma Group plc | 51.57M | 1.70% | 1,112,825 | 500.00K |
| 427 | LTRN | Lantern Pharma Inc. | 51.29M | -3.60% | 90,985 | - |
| 428 | VERU | Veru Inc. | 50.56M | 0.64% | 258,670 | 16.89M |
| 429 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.05M | -10.66% | 86,705 | - |
| 430 | CRVO | CervoMed Inc. | 49.24M | 17.42% | 1,568,208 | 2.09M |
| 431 | PDSB | PDS Biotechnology Corporation | 47.95M | -2.51% | 165,751 | - |
| 432 | HYPD | Hyperion DeFi, Inc. | 47.14M | -0.96% | 463,374 | 1.04M |
| 433 | RADX | Radiopharm Theranostics Limited | 46.59M | 1.43% | 25,779 | 10.86M |
| 434 | MGX | Metagenomi Therapeutics, Inc. | 45.55M | 1.68% | 110,296 | 22.33M |
| 435 | ABVC | ABVC BioPharma, Inc. | 45.23M | 13.29% | 245,213 | 797.92K |
| 436 | APLM | Apollomics, Inc. | 44.54M | -3.24% | 20,801 | 8.84M |
| 437 | INMB | INmune Bio Inc. | 43.87M | 1.23% | 623,695 | 50.00K |
| 438 | VRXA | Veraxa Biotech AG | 43.63M | -7.98% | 840,185 | - |
| 439 | RNXT | RenovoRx, Inc. | 42.75M | -3.28% | 168,154 | 1.49M |
| 440 | GNTA | Genenta Science S.p.A. | 42.23M | -2.72% | 126,599 | - |
| 441 | ESLA | Estrella Immunopharma, Inc. | 41.10M | -8.16% | 163,750 | - |
| 442 | NTRB | Nutriband Inc. | 36.95M | -4.70% | 21,237 | 1.80M |
| 443 | DYAI | Dyadic International, Inc. | 36.44M | 11.61% | 274,933 | 3.81M |
| 444 | GRCE | Grace Therapeutics, Inc. | 36.29M | -1.76% | 234,611 | - |
| 445 | ALGS | Aligos Therapeutics, Inc. | 33.84M | -5.23% | 61,274 | 4.71M |
| 446 | SNTI | Senti Biosciences Holdings, Inc. | 33.64M | -1.82% | 68,513 | 38.00K |
| 447 | ACTU | Actuate Therapeutics, Inc. | 33.50M | -8.50% | 97,132 | - |
| 448 | KALA | KALA BIO, Inc. | 33.46M | 4.05% | 200,347 | - |
| 449 | LITS | Lite Strategy, Inc. | 32.26M | 2.79% | 91,348 | - |
| 450 | DARE | Daré Bioscience, Inc. | 31.68M | 0.24% | 107,436 | 1.16M |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 30.79M | 0.13% | 84,489 | 90.00K |
| 452 | LSTA | Lisata Therapeutics, Inc. | 30.60M | -1.18% | 62,670 | 170.00K |
| 453 | KYNB | Kyntra Bio, Inc. | 30.37M | -0.62% | 3,562 | 7.44M |
| 454 | NNVC | NanoViricides, Inc. | 30.30M | -3.62% | 164,633 | - |
| 455 | PSTV | Plus Therapeutics, Inc. | 29.98M | -0.34% | 115,758 | 5.18M |
| 456 | GRDX | GridAI Technologies Corp. | 29.97M | -3.94% | 15,203 | - |
| 457 | SER | Serina Therapeutics, Inc. | 29.40M | 1.03% | 71,821 | 130.00K |
| 458 | BCTX | BriaCell Therapeutics Corp. | 28.43M | 6.48% | 145,213 | - |
| 459 | IGC | IGC Pharma, Inc. | 27.64M | 1.51% | 210,701 | 1.11M |
| 460 | BRNS | Barinthus Biotherapeutics plc | 26.99M | 0.12% | 33,533 | 14.97M |
| 461 | EVAX | Evaxion A/S | 26.94M | 4.19% | 32,400 | 7.53M |
| 462 | TVGN | Tevogen Bio Holdings Inc. | 26.38M | 11.31% | 20,545 | - |
| 463 | NRSN | NeuroSense Therapeutics Ltd. | 25.56M | 0.42% | 70,608 | - |
| 464 | MRKR | Marker Therapeutics, Inc. | 24.51M | - | 40,183 | 3.55M |
| 465 | SKYE | Skye Bioscience, Inc. | 24.38M | 0.05% | 53,398 | - |
| 466 | PLRZ | Polyrizon Ltd. | 23.75M | 1.36% | 13,164 | - |
| 467 | QNTM | Quantum BioPharma Ltd. | 23.20M | -5.59% | 201,208 | - |
| 468 | PLUR | Pluri Inc. | 23.20M | 2.87% | 2,096 | 1.08M |
| 469 | LGVN | Longeveron Inc. | 22.72M | 3.76% | 561,488 | 1.22M |
| 470 | VYNE | VYNE Therapeutics Inc. | 22.68M | 4.50% | 487,801 | 454.00K |
| 471 | CLRB | Cellectar Biosciences, Inc. | 22.30M | 0.36% | 66,619 | - |
| 472 | ALLR | Allarity Therapeutics, Inc. | 20.84M | 1.55% | 112,439 | 345.00K |
| 473 | NCEL | NewcelX Ltd. | 19.81M | 0.55% | 173,524 | - |
| 474 | LPCN | Lipocine Inc. | 19.79M | -6.25% | 62,024 | 2.00M |
| 475 | ICU | SeaStar Medical Holding Corporation | 19.62M | 32.97% | 440,070 | 1.44M |
| 476 | KTTA | Pasithea Therapeutics Corp. | 19.05M | 10.59% | 1,296,132 | - |
| 477 | PTN | Palatin Technologies, Inc. | 18.88M | -4.26% | 145,535 | 12.88M |
| 478 | AEON | AEON Biopharma, Inc. | 18.63M | -1.54% | 11,415 | - |
| 479 | CVM | CEL-SCI Corporation | 18.35M | 0.96% | 182,173 | - |
| 480 | TVRD | Tvardi Therapeutics, Inc. | 18.20M | 2.11% | 152,300 | - |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 18.00M | -23.80% | 476,716 | -13.27K |
| 482 | ATOS | Atossa Therapeutics, Inc. | 17.65M | 6.22% | 116,018 | - |
| 483 | GTBP | GT Biopharma, Inc. | 17.65M | -0.08% | 1,138,070 | - |
| 484 | CELU | Celularity Inc. | 17.42M | 0.67% | 38,363 | 26.55M |
| 485 | HOWL | Werewolf Therapeutics, Inc. | 17.25M | -1.39% | 1,308,926 | 1.14M |
| 486 | CRIS | Curis, Inc. | 17.14M | -17.87% | 3,804,467 | 7.06M |
| 487 | CTXR | Citius Pharmaceuticals, Inc. | 16.59M | -0.02% | 316,042 | 5.61M |
| 488 | TPST | Tempest Therapeutics, Inc. | 16.36M | -0.46% | 38,415 | - |
| 489 | CALC | CalciMedica, Inc. | 16.11M | -0.97% | 918,675 | - |
| 490 | QNCX | Quince Therapeutics, Inc. | 16.11M | -9.46% | 102,160 | - |
| 491 | MLEC | Moolec Science SA | 15.94M | 2.54% | 5,838 | 7.83M |
| 492 | HIND | Vyome Holdings, Inc. | 15.44M | 2.33% | 20,960 | 152.72K |
| 493 | BIVI | BioVie Inc. | 15.39M | 5.15% | 297,216 | - |
| 494 | COCP | Cocrystal Pharma, Inc. | 14.61M | 0.95% | 30,633 | 225.00K |
| 495 | LEXX | Lexaria Bioscience Corp. | 14.37M | 3.55% | 13,242 | 368.00K |
| 496 | PASG | Passage Bio, Inc. | 14.24M | -9.02% | 50,885 | - |
| 497 | CYCN | Cyclerion Therapeutics, Inc. | 14.21M | -1.18% | 23,181 | 1.99M |
| 498 | MBRX | Moleculin Biotech, Inc. | 14.03M | -5.73% | 620,306 | - |
| 499 | LNAI | Lunai Bioworks Inc. | 13.92M | -6.12% | 78,528 | 20.94K |
| 500 | INAB | IN8bio, Inc. | 13.88M | - | 14,857 | - |